コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
6 luripotent stem cells (iPSCs) to investigate supravalvular aortic stenosis (SVAS) patients and/or ela
7 ontrol subjects, four patients with isolated supravalvular aortic stenosis (SVAS), and five patients
8 een previously reported in two patients with supravalvular aortic stenosis (SVAS), and SVAS is also a
13 For example, the molecular genetic cause of supravalvular aortic stenosis and the heart disease asso
14 izing aortic root atherosclerotic plaque and supravalvular aortic stenosis in HFH patients but also s
16 ation of the genetic defect in patients with supravalvular aortic stenosis is essential for a definit
18 mutations leading to protein insufficiency (supravalvular aortic stenosis) or from missense mutation
25 S); associated lesions included subAS (n=9), supravalvular AS (n=2), coarctation (n=5), and interrupt
26 -10.3 mm); these locations were confirmed as supravalvular by direct intracardiac echocardiography vi
27 ssociated right ventricular outflow tract or supravalvular pulmonary stenosis, including optimal use